p. 9211 - 9222
(2021/11/16)p. 12089 - 12108
(2021/09/06)p. 12705 - 12716
(2021/11/17)(2021/03/16)
(2021/06/03)
(2020/09/18)
p. 1610 - 1620
(2018/03/21)p. 2613 - 2616
(2017/05/10)(2017/07/01)
p. 3841 - 3843
(2016/08/02)p. 64544 - 64556
(2016/07/21)p. 1139 - 1143
(2016/03/01)p. 259 - 274
(2015/05/27)p. 45 - 52
(2015/10/12)p. 777 - 784
(2016/01/12)p. 550 - 552
(2015/11/27)(2015/07/22)
p. 8933 - 8948
(2014/08/05)p. 60 - 61
(2014/02/14)p. 153 - 164
(2014/09/29)p. 3542 - 3544
(2013/05/08)p. 1377 - 1383,7
(2020/09/02)p. 4344 - 4351
(2011/07/29)p. 5278 - 5280
(2011/02/21)p. 6047 - 6053
(2010/09/11)(2009/11/30)
p. 2647 - 2655
(2007/10/03)p. 788 - 795
(2007/10/03)p. 8907 - 8909
(2007/10/03)p. 73 - 74
(2007/10/03)p. 1559 - 1565
(2007/10/02)p. 82 - 87
(2007/10/02)p. 407 - 408
(2007/10/02)p. 169 - 170
(2007/10/02)p. 393 - 396
(2007/10/02)p. 526 - 526
(2007/10/02)p. 221 - 222
(2007/10/02)p. 313 - 318
(2007/10/02)p. 1003 - 1006
(2007/10/02)diazomethane
quercetin-3-O-glucoside
methyl iodide
2'-hydroxy-3,4,4',6'-tetramethoxychalcone
1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)propane-1,3-dione